- In 2020, the United States Department of Health announced the "New Vision" project, aiming to put regenerative medicine and stem cell therapy at the forefront of healthcare.
- In April 2020, Tissue Regeneration Technologies (TRT) announced a significant addition to our patent family, which could help in the fight against the Coronavirus. This patent uses the well-understood processes of unfocused shockwaves to combat this deadly pathogen.
Frequently Asked Questions
The market is segmented based on Asia-Pacific (APAC) Tissue Regeneration Market Segmentation, By Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing, Others), Raw Material (Synthetic, Genetically Modified, Biologic), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Opthalmology, Others), End-User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) – Industry Trends and Forecast to 2032.
.
The Asia Pacific Tissue Regeneration Market size was valued at USD 19.48 USD Billion in 2024.
The Asia Pacific Tissue Regeneration Market is projected to grow at a CAGR of 14.5% during the forecast period of 2025 to 2032.
The market report covers data from the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
